Fundraising Fox
Lyra Therapeutics
Founded 2018 · 25 employees on LinkedIn · 1 known investors
Find your way into Lyra Therapeutics
Sign up to see every warm intro you have to Lyra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lyra Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.
Investors · 1
Frequently asked questions
- What does Lyra Therapeutics do?
- Lyra Therapeutics develops biocompatible mesh scaffolds for sustained drug delivery to the sinonasal passages, targeting treatment of chronic rhinosinusitis. The company's proprietary platform uses bioabsorbable polymers and engineered matrices to deliver medication over up to six months with a single administration.
- Who are Lyra Therapeutics's investors?
- Lyra Therapeutics's investors include Broadview Ventures.